Nektar Therapeutics releases positive results from its trial for the treatment of alopecia areata.

Share on Pinterest FDA approves Olumiant for the treatment of severe alopecia. Image credit: Wirestock Creators/Shutterstock. There are several forms of alopecia, including alopecia areata, an ...

Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced new results from a blinded 16-week treatment extension ...

Traction alopecia is a type of hair loss caused by hairstyles or other things that pull on your hair. This is most often due to wearing tight hairstyles, but it can also come from wearing caps or ...

Patients with ophiasis may be categorized into 3 distinct subtypes that can guide early intervention and stratify treatment.

Detailed price information for Nektar Therapeutics (NKTR-Q) from The Globe and Mail including charting and trades.

Shares of Nektar Therapeutics surged Monday after the company reported promising results for its experimental alopecia treatment.

Alopecia affects QOL, with non-scarring alopecia patients experiencing higher anxiety and depressive symptoms than those with scarring alopecia. Younger patients and women report greater psychological ...

Nektar Therapeutics (NASDAQ:NKTR) presented 52-week top-line results from a 16-week blinded treatment extension of its Phase ...

Alopecia is a condition that causes hair loss. It’s an autoimmune condition that damages hair follicles. Alopecia can affect hair on your scalp, eyebrows, or anywhere on your body. Hair may come out ...

Patchy alopecia areata involves patches of hair loss on the scalp; it occasionally happens on other areas of the body, too. This is the most common type of alopecia areata, and it tends to cause hair ...